An Analysis of Amylyx Pharmaceuticals Inc (AMLX)’s Potential Price Growth

Amylyx Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer FRATES JAMES M unloaded Company’s shares for reported $37806.0 on Mar 31 ’25. In the deal valued at $3.47 per share,10,896 shares were sold. As a result of this transaction, FRATES JAMES M now holds 290,988 shares worth roughly $1.87 million.

Then, Bedrosian Camille L sold 12,425 shares, generating $43,082 in total proceeds. Upon selling the shares at $3.47, the Chief Medical Officer now owns 194,375 shares.

Before that, Mazzariello Gina sold 9,192 shares. Amylyx Pharmaceuticals Inc shares valued at $31,954 were divested by the Chief Legal Officer at a price of $3.48 per share. As a result of the transaction, Mazzariello Gina now holds 187,969 shares, worth roughly $1.2 million.

Guggenheim initiated its Amylyx Pharmaceuticals Inc [AMLX] rating to a Buy in a research note published on June 24, 2025; the price target was $17. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. TD Cowen began covering AMLX with “Buy” recommendation on May 30, 2025. Mizuho revised its rating on April 07, 2025. It rated AMLX as “an Outperform” which previously was an “a Neutral”.

Price Performance Review of AMLX

On Tuesday, Amylyx Pharmaceuticals Inc [NASDAQ:AMLX] saw its stock unchanged to $6.41. Amylyx Pharmaceuticals Inc shares have risen nearly 232.12% since the year began. Nevertheless, the stocks have risen 69.58% over the past one year. While a 52-week high of $7.27 was reached on 06/24/25, a 52-week low of $1.62 was recorded on 03/04/25.

Levels Of Support And Resistance For AMLX Stock

The 24-hour chart illustrates a support level at 6.22, which if violated will result in even more drops to 6.04. On the upside, there is a resistance level at 6.56. A further resistance level may holdings at 6.71.

How much short interest is there in Amylyx Pharmaceuticals Inc?

A steep rise in short interest was recorded in Amylyx Pharmaceuticals Inc stocks on 2025-06-13, dropping by -0.93 million shares to a total of 4.04 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 4.97 million shares. There was a decline of -23.09%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.